Mostrar el registro sencillo del ítem

dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.contributor.authorKuzmar, Isaac
dc.contributor.authorGiraldo Ospina, Carlos Eduardo
dc.contributor.authorAcevedo Osorio, Germán Oved
dc.contributor.authorRua Salas, Guido
dc.date.accessioned2018-06-22T14:30:51Z
dc.date.available2018-06-22T14:30:51Z
dc.date.issued2018
dc.identifier.issn00146722
dc.identifier.urihttp://hdl.handle.net/20.500.12442/2126
dc.description.abstractObjetivo: relacionar las morbilidades de los pacientes pertenecientes al programa de EPOC de una institución de salud del municipio de Anserma, Caldas (Colombia). Material y Métodos: estudio descriptivo de 51 pacientes a quienes les fueron tomadas espirometrías exploratorias, los hallazgos fueron contrastados con las principales comorbilidades registradas en la Historia Clínica a través de estadística descriptiva e inferencial. Resultados: 50% presentaron al menos una comorbilidad registrada, principalmente la Hipertensión Arterial seguida de la Enfermedad Renal Crónica, se encontró un comportamiento asociado entre la clasificación GOLD y la presencia de síntomas con valores no estadísticamente significativos; no se encontró asociación estadísticamente significativa entre las comorbilidades y los valores espirométricos. Conclusiones: se hacen necesarias nuevas investigaciones que valoren de forma clara la causalidad en la población colombiana.spa
dc.description.abstractObjective: to relate the morbidities of patients belonging to the COPD program of a health institution in Anserma, Caldas (Colombia). Material and Methods: a descriptive study was presented with a sample of 51 patients who underwent exploratory spirometry, the findings were contrasted with the main commodities reported by the patients or the Medical Record through descriptive and inferential statistics. Results: 50% of the evaluated population had at least one recorded comorbidity; the main morbidity found was Arterial Hypertension followed by Chronic Kidney Disease; an associated behavior was found between the GOLD classification and the presence of symptoms with non-statistically significant values; no statistically significant association was found between comorbidities and spirometric values. Conclusions: new research is needed that clearly values causality in the Colombian population.eng
dc.language.isospaspa
dc.publisherSecretaría de Ciencia y Tecnología de la Facultad de Ciencias Médicas de la Universidad Nacional de Córdobaspa
dc.sourceVol. 75, No.1 (2018)spa
dc.sourceRevista de la Facultad de Ciencias Médicasspa
dc.source.urihttps://revistas.unc.edu.ar/index.php/med/article/view/16617spa
dc.subjectEPOCspa
dc.subjectMorbilidadesspa
dc.subjectEspirometríaspa
dc.subjectColombiaspa
dc.subjectSíntomasspa
dc.subjectCOPDeng
dc.subjectMorbiditieseng
dc.subjectSpirometryeng
dc.subjectSymptomseng
dc.titleMorbilidad de la enfermedad pulmonar obstructiva crónica en Colombia. Resultados del estudio sanepoc-2spa
dc.title.alternativeMorbidity of chronic obstructive pulmonary disease in Colombia. Results of the study sanepoc-2eng
dc.typearticlespa
dcterms.referencesVestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2012, 187(4):347–365.eng
dcterms.referencesMenezes Ana y cols. PROYECTO LATINOAMERICANO DE INVESTIGACIÓN EN OBSTRUCCIÓN PULMONAR. Libro oficial. Capítulo 1. www.platino-alat.orgeng
dcterms.referencesWORLD HEALTH STATISTICS2014. WORLD HEALTH ORGANIZATIONWHO Library Cataloguing-in-Publication Data. ISBN 978 92 4 069267 1 (PDF)eng
dcterms.referencesAnaMBMenezes, Cesar G Victora, Rogelio Perez-Padilla and the PLATINO Team. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Medical Research Methodology 2004, 4:15 doi:10.1186/1471-2288-415eng
dcterms.referencesBuist Sonia McBurnie Mary Ann et al. International variation in the prevalence of COPD(The BOLD Study): a population-based prevalence studyLancet 2007; 370: 741–50eng
dcterms.referencesAraya Marcela et al. Calidad de las espirometrías en un estudio epidemiológico de terreno. Factores determinantes de la necesidad de repetir el examen en el estudio Platino-Chile. Rev Chil Enf Respir 2005; 21: 155-163Rev Chil Enf Respir 2005; 21: 155-163Rev Chil Enf Respir 2005; 21: 155-163Rev Chil Enf Respir 2005; 21: 155-163Rev Chil Enf Respir 2005; 21: 155-1eng
dcterms.referencesBuist Sonia McBurnie Mary Ann et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study Lancet 2007; 370: 741–50eng
dcterms.referencesVestboJ.Anderson W. et al.Evaluation of COPD Longitudinallyto Identify Predictive SurrogateEnd-points (ECLIPSE).EurRespir J 2008; 31: 869–873DOI: 10.1183/09031936.00111707CopyrightERS Journals Ltd 2008eng
dcterms.referencesAmerican Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107– 1136eng
dcterms.referencesCaballero Andres et al. Prevalence of COPD in Five ColombianCities Situated at Low, Medium, andHigh Altitude (PREPOCOL Study)*.CHEST/133/2/ FEBRUARY, 2008eng
dcterms.referencesNoriane a. Sievi, oliver senn,thomas brack et al.Impact of comorbidities on physical activity in COPD. Respirology (2015) 20, 413–418 © 2015 Asian Pacific Society of Respirologyeng
dcterms.referencesBartolome R. Celli, Claudia G. Cote, Jose M. Marin et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. n engl j med 350;10 www.nejm.org march 4, 2004eng
dcterms.referencesIrene Torres-Sánchez, Elisabeth Rodríguez-Alzueta, Irene Cabrera-Martos et al. Cognitive impairment in COPD: a systematic review. J Bras Pneumol. 2015;41(2):182-190. http://dx.doi.org/10.1590/S1806-37132015000004424eng
dcterms.referencesFausto Aloísio Pedrosa Pimentaa, Maria Aparecida Camargos Bicalhob, Marco Aurélio Romano-Silva.Chronic diseases, cognition, functional decline, and the Charlson index in elderly people with dementia. REV ASSOC MED BRAS. 2013;59(4):326-334eng
dcterms.referencesBlack-Shinn, Kinney GL, Wise AL, Regan EA, Make B y cols. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD. 2014 Sep;11(5):546-51. doi: 10.3109/15412555.2014.898029. Epub 2014 May 15.eng
dcterms.referencesCraig P Hersh1, Barry J Make, David A Lynch, et al.Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. Hersh et al. BMC Pulmonary Medicine 2014, 14:164 http://www.biomedcentral.com/1471-2466/14/164eng
dcterms.referencesIrene Torres-Sánchez, Marie Carmen Valenza, Fernando Carrasco et al. Alteraciones endocrinometabólicas en la enfermedad pulmonar obstructiva crónica. Nutr Hosp. 2013;28(4):1022-1030 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318eng
dcterms.referencesCalverley P, Anderson J, Celli B, Ferguson G, Jenkins C, Jones P et al. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. N Engl J Med 2007; 356: 775-89.eng
dcterms.referencesVestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R, ECLIPSE Investigators: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31(4):869–873.eng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem